Dual Inhibitors Targeting DNA and Histone Deacetylases
Histone deacetylases (HDACs) regulate the acetylation status of histones and structural status of chromatin. The chromatin structure becomes relaxed after inhibition of HDAC, leading to DNA exposed to DNA disrupting agents, and eventually causing DNA dysfunction. Recently, more and more dual inhibit...
Main Authors: | Chen Chen, Xinying Yang, Xuben Hou, Hao Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2020-06-01
|
Series: | Pharmaceutical Fronts |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1713873 |
Similar Items
-
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone
by: Yang Lin, et al.
Published: (2020-09-01) -
Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
by: Lihui Zhang, et al.
Published: (2019-08-01) -
Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
by: Hang Dong, et al.
Published: (2019-06-01) -
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
by: Guo Li, et al.
Published: (2020-09-01) -
Improving histone deacetylase inhibition therapy through isoform selectivity and targeted delivery
by: Sodji, Quaovi Hemeka
Published: (2015)